Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Safety and Effectiveness of Dienogest (Visanne®) for Treatment of Endometriosis: A Large Prospective Cohort Study

Cho, BaikSeol, Roh, Ju-Won, Park, Jonghoon, Jeong, Kyungah, Kim, Tae-Hee, Kim, Yun Sook, Kwon, Yong-Soon, Cho, Chi-Heum, Park, Sung Ho, Kim, Sung Hoon · 2020 · Reproductive Sciences

Abstract

Dienogest (DNG) is a progestin with highly selective progesterone activity and known to be effective in the treatment of endometriosis. This prospective cohort study in patients who had been treated with DNG 2 mg (Visanne ® ) for endometriosis was conducted to assess the safety and effectiveness of DNG in a large Korean cohort. This study included 3356 patients with endometriosis from 73 centers in Korea. All patients were treated with DNG 2 mg daily and were followed up for at least 6 months after initial visit. Any adverse events were recorded including severity, onset/closing date, outcomes, treatments, and the causality with DNG. Effectiveness of DNG was measured by changes in visual analogue scale (VAS) from baseline at the end of follow-up. The mean age of the subjects was 34.96 years, and the mean duration of treatment was 285.44 days. Incidence of adverse drug reaction (ADR) was 13.27% (413/3113). The most frequently reported ADR were "abnormal uterine bleeding" 4.14% (129/3113), "increased weight" 2.57% (80/3113), and "headache" 1.22% (38/3113). The number of patients (%) with favorable bleeding patterns was observed to increase as the duration of treatment increases. Amenorrhea was observed in 29.63%, 41.25%, 46.26%, and 53.20% of patients at 3 months, 6 months, 12 months, and more than 12 months follow-up period, respectively. The mean (±SD) VAS change from baseline at the last follow-up visit was -28.19 ± 28.39 mm (P value < 0.0001). This large cohort study confir…

Overview

Integrity signals

Registry

Crossref · 10.1007/s43032-019-00094-5

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

1 retracted

Show all 39 references

Research works printed but not linked: 3

  1. Prentice A, Deary AJ, Bland E. Progestogens and anti-progestogens for pain associated with endometriosis. Cochrane Database Syst Rev. 2000;2:CD002122.
  2. Oettel M, Carol W, Elger W. A 19-norprogestin without 17a-ethinyl group II: dienogest from a pharmacodynamic point of view. Drugs Today. 1995;31:517–36.
  3. Guy W. ECDEU Assessment Manual for Psychopharmacology (028 clinical global impressions [CGI]). Rockville: National Institutes of Health; 1976. p. 218–22.

Cited by

See all 44

Metadata

Authors
Cho, B., Roh, J.-W., Park, J., Jeong, K., Kim, T.-H., Kim, Y. S., Kwon, Y.-S., Cho, C.-H., Park, S. H., & Kim, S. H.
Affiliations
  • Dongguk University Ilsan Hospital (KR)
  • BongSeng Memorial Hospital (KR)
  • Ewha Womans University (KR)
  • Soonchunhyang University Hospital Bucheon (KR)
  • Soonchunhyang University (KR)
  • Ulsan University Hospital (KR)
  • Keimyung University (KR)
  • Hallym University (KR)
  • Asan Medical Center (KR)
Corresponding author
Kim, Sung Hoon
Venue
Reproductive Sciences
Published
2020-02-12
Volume
27
Issue
3
Pages
905-915
ISSN
  • 1933-7191 (ISSN-L)
  • 1933-7205
OpenAlex
W3005684753
Cited by
44
References
39
Citations by year
2026: 10 · 2025: 7 · 2024: 10 · 2023: 7 · 2022: 6 · 2021: 4
FWCI
3.75
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Reproductive Sciences (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Health Sciences › Medicine › Obstetrics and Gynecology › Ectopic Pregnancy Diagnosis and Management
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Menstrual Health and Disorders
Keywords
endometriosis, dienogest, adverse drug reactions, abnormal uterine bleeding, amenorrhea, analgesia, treatment safety, treatment effectiveness, Korean patients
MeSH terms
Adult, Endometriosis, Female, Hormone Antagonists, Humans, Middle Aged, Nandrolone, Pain, Prospective Studies, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Safety and Effectiveness of Dienogest (Visanne®) for Treatment of Endometriosis: A Large Prospective Cohort Study. https://app.cochat.ai/papers/10.1007/s43032-019-00094-5
The paper
Cho, B., Roh, J.-W., Park, J., Jeong, K., Kim, T.-H., Kim, Y. S., Kwon, Y.-S., Cho, C.-H., Park, S. H., & Kim, S. H. (2020). Safety and Effectiveness of Dienogest (Visanne®) for Treatment of Endometriosis: A Large Prospective Cohort Study. Reproductive Sciences. https://doi.org/10.1007/s43032-019-00094-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.